J David Gladstone Institutes is a 501(c)(3) organization based in San Francisco, California, registered in 1973, with $119,155,911 in FY2024 revenue. CharityIndex grades it B+, and it directs about 85% of spending to programs.
Revenue (FY2024)
$119.2M
▼ 0.0% vs prior year
Medical Research median: $217K
Expenses (FY2024)
$144.8M
Net assets
$167.6M
Employees
593
Measures how much of every dollar spent actually reaches programs, plus what it costs to raise $100 of donations. The worse of the two measures sets the letter (85%+ to programs is an A; under $15 to raise $100 is an A), averaged over the three most recent filings. For J David Gladstone Institutes: 85% to programs · $15 to raise $100 earns a A on this criterion. See the exact thresholds →
Measures whether the organization is built to last: how many months its reserves would cover expenses (3+ months earns an A-range score, but hoarding 5+ years of budget is capped) and whether it runs a surplus or a deficit. For J David Gladstone Institutes: 14 mo reserves · -22% margin earns a C+ on this criterion. See the exact thresholds →
Checks how the organization is run, from its own Form 990: an independent board majority, a board of five or more, conflict-of-interest, whistleblower and document-retention policies, and independently audited financials. The share of disclosed checks that pass sets the letter. For J David Gladstone Institutes: 4 of 6 checks met earns a B on this criterion. See the exact thresholds →
Counts five disclosure signals: a recent filing, a mission statement, program descriptions, a listed website, and the full expense breakdown. More disclosure, better letter. For J David Gladstone Institutes: 5 of 5 disclosure signals earns a A+ on this criterion. See the exact thresholds →
Show this grade on your website
A live seal — it updates automatically when the grade changes and links donors to this verified profile.
To drive a new era of discovery in disease oriented science and to mentor tomorrow's leaders in an inspiring and diverse environment.
The institute of virology has made significant contributions to fight hiv/aids, sars-cov-2, hepatitis c, zika, and cytomegalovirus infections leading to global and groundbreaking efforts in hiv prevention and cure. its state of the art bsl3 laboratories have allowed gladstone to do groundbreaking work in understanding the covid-19 virus and other virus driven diseases. by focusing on prevention, diagnosis, and therapeutics, the institute aims to develop proactive strategies to tackle current and future pandemics.
The institute of cardiovascular disease leverages important genetic, developmental, chemical, biological systems, computational, and engineering approaches to study heart disease and stem cell biology.
The gladstone institute of data science and biotechnology invests in talent to create new ways to analyze and integrate datasets, including machine learning approaches that leverage the rapid advances in artificial intelligence. it will be the home for development of new technologies that can accelerate discovery in all areas of investigation at gladstone. gladstone - ucsf institute of genomic immunology blends the latest genomics and genome engineering technologies with immunology research to engineer the human immune system for therapeutic benefit.
Revenue grew from $80.2M (FY2013) to $119.2M (FY2024) across 12 reported years.
Financial snapshot
Operating margin
-21.5%
Spent more than it raised in the latest fiscal year.
Total assets
$372.0M
Total liabilities
$204.4M
Net assets
$167.6M
Salaries & benefits
$75.4M
52% of expenses
Board members
3
0 independent
| Fiscal year | Revenue | Expenses | Net assets | Total assets | Form |
|---|---|---|---|---|---|
| 2024 | $119,155,911 | $144,808,821▲13.4% | $167,595,974▼2.8% | $371,967,489▲1.8% | 990 |
| 2023 | $119,208,526▼17.7% | $127,669,032▲7.3% | $172,425,834▲2.9% | $365,291,245▲1.9% | 990 |
| 2022 | $144,774,821▲1.2% | $118,956,646▲15.5% | $167,643,324▼4.8% | $358,330,486▼2.5% | 990 |
| 2021 | $143,049,979▲69.7% | $103,017,350▲10.2% | $176,125,318▲45.8% | $367,466,101▲15.4% | 990 |
| 2020 | $84,274,665▲34.1% | $93,512,759▲13.7% | $120,832,260▼3.2% | $318,407,379▲1.3% | 990 |
| 2019 | $62,831,350▼27.2% | $82,269,244▼1.6% | $124,840,825▼4.8% | $314,172,354▲22.0% | 990 |
| 2018 | $86,315,298▲2.0% | $83,576,420▼0.4% | $131,097,832▼1.1% | $257,431,204▼4.9% | 990 |
| 2017 | $84,597,148▲25.5% | $83,899,382▼0.8% | $132,603,348▲11.4% | $270,741,190▲4.2% | 990 |
| 2016 | $67,385,094▲0.8% | $84,543,592▲2.0% | $119,024,862▼9.9% | $259,825,160▼2.3% | 990 |
| 2015 | $66,831,559▼22.6% | $82,885,330▲1.6% | $132,056,072▼14.5% | $265,965,861▼7.4% | 990 |
| 2014 | $86,317,449▲7.7% | $81,593,162▲3.5% | $154,449,352▼0.3% | $287,366,861▼1.6% | 990 |
| 2013 | $80,164,886 | $78,842,979▼4.9% | $154,940,589▼0.7% | $292,117,051▼6.2% | 990 |
| 2012 | — | $82,921,017▼4.3% | $155,978,606▲2.0% | $311,301,015▼2.6% | 990 |
| 2011 | — | $86,638,584▲10.0% | $152,935,255▼12.2% | $319,515,917▼5.5% | 990 |
| 2010 | — | $78,754,762 | $174,133,130 | $338,133,259 | 990 |
Original Form 990 PDFs (the Form column) are served by ProPublica Nonprofit Explorer, as filed with the IRS. Create a free account to download the CSV report.
Highest-paid: Deepak Srivastava — $1,088,619 (0.75% of total expenses)
| Name | Title | Hours/week | Compensation |
|---|---|---|---|
| Deepak Srivastava | President | 40 | $1,088,619 |
| Alex Marson | Director | 40 | $669,747 |
| Robert Obana | Coo | 40 | $631,301 |
| Lennart Mucke | Director | 40 | $621,959 |
| Steven M Finkbeiner | Director | 40 | $565,340 |
| Melanie Ott | Director | 40 | $550,286 |
| Katherine Pollard | Director | 40 | $529,666 |
| Benoit Bruneau | Director | 40 | $525,543 |
| Jennifer Crosby | Vp of People Services | 40 | $491,851 |
| Stephen Freedman | Vp For Corp Liaison & Ventures | 40 | $489,679 |
| Robert Wicks | Vp of Philanthropy | 40 | $448,823 |
| Andrew S Garb | Trustee | 3 | $425,000 |
| Nicholas J Simon | Trustee | 3 | $425,000 |
| William Price | Trustee | 3 | $425,000 |
| Katerina Akassoglou | Sr. Investigator | 40 | $389,340 |
| Michelle Sibly | Vp of Finance | 40 | $375,123 |
| Contractor | Services | Paid |
|---|---|---|
| Service By Medallion | Custodial Services | $640,917 |
| Schwegman Lundberg Woessner | Legal Services | $609,129 |
| Moss Adams LLP | Accounting Services | $259,626 |
| Goodwin Procter LLP | Legal Services | $216,990 |
| Dg Architects Inc | Architectural Services | $197,129 |
170 grants to J David Gladstone Institutes totaling $68.2M, reported by foundations on their Schedule I filings — showing the 15 most recent.
| Grantmaker | Purpose | Year | Amount |
|---|---|---|---|
| The Milken Institute | Transformative computational biology | 2024 | $4,843,866 |
| Silicon Valley Community Foundation | Health | 2024 | $3,263,650 |
| Parker Institute For Cancer Immunotherapy | Support research in field of cancer immunotherapy | 2024 | $2,685,423 |
| American Heart Association Inc | Research | 2024 | $314,960 |
| Brightfocus Foundation | Alzheimer's disease research by katerina akassoglou, phd entitled: a2025013s | 2024 | $300,000 |
| American Endowment Foundation | Medical research | 2024 | $70,000 |
| Morgan Stanley Global Impact Funding Trust Inc | Unrestricted general support | 2024 | $40,000 |
| American Association For the Advancement of Science | Support women in science | 2024 | $30,000 |
| Parker Institute For Cancer Immunotherapy | Support research in field of cancer immunotherapy | 2023 | $2,644,109 |
| Silicon Valley Community Foundation | Health | 2023 | $605,000 |
| National Philanthropic Tr | Culture & arts | 2023 | $520,000 |
| Alzheimers Disease and Related Disorders Association Inc | Program support | 2023 | $500,000 |
| American Heart Association Inc | Research | 2023 | $451,564 |
| Washington University | Research | 2023 | $388,509 |
| Scripps Research Institute | Grants for scientific research | 2023 | $284,185 |
Explore more
Data for J David Gladstone Institutes (EIN 23-7203666) comes from the IRS Business Master File and e-filed Form 990 returns, via CharityIndex. Figures reflect what the organization reported to the IRS for each fiscal year.